PHGE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BiomX Inc (PHGE) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company is facing significant challenges, including leadership instability, poor financial performance, and bearish technical indicators. Additionally, there are no positive catalysts or strong trading signals to support a buy decision.
The technical indicators for PHGE are bearish. The MACD is negative and contracting, RSI is at 6.751 indicating oversold conditions, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with a high probability of further downside (-0.93% next day, -4.59% next week, -9.89% next month).
NULL identified.
The resignation of both the CEO and Chairman of the Board raises concerns about the company's leadership and future direction. Financial performance is deteriorating, with declining net income and EPS. Analysts have downgraded the stock to Neutral, citing significant challenges.
In Q4 2025, BiomX reported zero revenue growth, a net income loss of -$13.34M (down -8.10% YoY), and a significant EPS drop of -45.86% YoY to -8.18. Gross margin remains at 0%. The financials indicate poor performance and no growth trends.
H.C. Wainwright downgraded the stock to Neutral from Buy on March 9, 2026, citing leadership instability and concerns about the company's future path.
